Stuart H. Burri, MD

Find Dr. Burri’s full list of publications on PubMed here.

• Trifiletti DM, Akinyelu T, Burri SH, Jeudy A, Quinones-Hinojosa A, Prabhu RS. Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety. Journal of Neuro-Oncology, 2023 Mar
• Germano IM, Sheehan J, Parish J, Atkins T, Asher A, Hadjipanayis CG, Burri SH, Green S, Olson JJ. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas. Neurosurgery. 2018 Feb 1;82(2):E49-E51. doi: 10.1093/neuros/nyx515. PMID: 29309637
• Prabhu RS, Patel KR, Press RH, Soltys SG, Brown PD, Mehta MP, Asher AL, Burri SH. Pre-operative versus Post-operative Radiosurgery For Resected Brain Metastases: A Review. Neurosurgery, In press.
• Prabhu RS, Press RH, Boselli DM, Miller KR, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Patel KR, Asher AL, Sumrall AL, Curran WJ, Shu HKG, Crocker IR, Burri SH. External Validity of Two Nomograms for Predicting Distant Brain Failure After Radiosurgery for Brain Metastases in a Bi-institutional Independent Patient Cohort. In press Journal of Neuro-Oncology. December 2017.
• Burri SH, Gondi V, Brown PD, Mehta MP. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists. American Journal Clinical Oncology. 2017 Aug 24. doi: 10.1097/COC.0000000000000395
• Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. International Journal Radiation Oncology Biology Physics. 2017 Aug 5. pii: S0360-3016(17)33691-X. doi: 10.1016/j.ijrobp.2017.07.045.
• Prabhu RS, Press RH, Patel KR, Boselli DM, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Asher AL, Sumrall AL, Buchwald ZS, Curran WJ, Jr., Shu HG, Crocker I, Burri SH. Single-fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS for large brain metastases: A multi-institutional analysis. International Journal of Radiation Oncology, Biology, Physics 2017;99:459-467.
• Press RH, Boselli DM, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Burri SH, Patel KR, Asher AL, Sumrall AL, Curran WJ, Jr., Shu HG, Crocker IR, Prabhu RS. External validity of a risk stratification score predicting early distant brain failure and salvage whole brain radiation therapy after stereotactic radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics 2017;98:632-638.
• Patel KR, Burri SH, Boselli D, Symanowski JT, Asher AL, Sumrall A, Fraser RW, Press RH, Zhong J, Cassidy RJ, Olson JJ, Curran WJ, Shu HG, Crocker IR, Prabhu RS. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis. Journal of Neuro-Oncology. 2017; 131:611-618
• Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. Journal of the American Medical Association (JAMA). 2016 July 26;316(4):401-9.
• Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Prabhu RS. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis. Neurosurgery. 2016 Aug;79(2):279-85.
• Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncology. 2016 Apr;18(4):565-74.
• Simone CB 2nd, Burri SH, Heinzerling JH. Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies. Translational Lung Cancer Research. 2015 Oct;4(5):545-52
• Burri SH, Prabhu RS, Sumrall AL, Brick W, Blaker BD, Heideman BE, Boltes P, Kelly R, Symanowski JT, Wiggins WF, Ashby L, Norton HJ, Judy K, Asher AL. BCNU Wafer Placement with Temozolomide (TMZ) in the Immediate Postoperative Period after Tumor Resection Followed by Radiation Therapy with TMZ in Patients With Newly Diagnosed High Grade Glioma: Final Results of a Prospective, Multi-institutional, Phase II Trial. Journal of Neuro-Oncology. 2015 Jun;123(2):259-66.
• Wait SD, Prabhu RS, Burri SH, Atkins TG, Asher AL. Polymeric drug delivery for the treatment of glioblastoma. Neuro-Oncology. 2015 Mar;17 Suppl 2:ii9-ii23.
• Asher AL*, Burri SH*, Wiggins WF, Kelly RP, Boltes MO, Mehrlich M, Norton HJ, Fraser RW. A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. International Journal of Radiation Oncology Biology Physics.2014 Mar 15;88(4):899-906. *=co-first authors
• Gaspar LE, MP Mehta, RA Patchell, SH Burri, PD Robinson, RE Morris, M. Ammirati, DW Andrews, AL Asher, CS Cobbs, D. Kondziolka, ME Linskey, JS Loeffler, M. McDermott, T. Mikkelsen, JJ Olson, NA Paleologos, TC Ryken, SN Kalkanis. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Kalkanis SN, D Kondziolka, LE Gaspar, SH Burri, AL Asher, CS Cobbs, M Ammirati, PD Robinson, DW Andrews, JS Loeffler, M McDermott, MP Mehta, T Mikkelsen, JJ Olson, NA Paleologos, RA Putchell, TC Ryken, ME Linskey. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Linskey ME, DW Andrews, AL Asher, SH Burri, D Kondziolka, PD Robinson, M Ammirati, CS Cobbs, LE Gaspar, JS Loeffler, M McDermott, MP Mehta, T Mikkelsen, JJ Olson, NA Paleologos, RA Patchell, TC Ryken, SN Kalkanis. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidenced-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Mehta MP, NA Paleologos, T Mikkelsen, PD Robinson, M Ammirati, DW Andrews, AL Asher, SH Burri, CS Cobbs, LE Gaspar, D Kondziolka, ME Linskey, JS Loeffler, M McDermott, JJ Olson, RA Patchell, TC Ryken, SN Kalkanis. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Ammirati M, CS Cobbs, ME Linskey, NA Paleologos, TC Ryken, SH Burri, AL Asher, JS Loeffler, PD Robinson, DW Andrews, LE Gaspar, D Kondziolka, M McDermott, MP Mehta, T Mikkelsen, JJ Olson, RA Patchell, SN Kalkanis. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Mikkelsen T, NA Paleologos, PD Robinson, M Ammirati, DW Ansrews, AL Asher, SH Burri, CS Cobbs, LE Gaspar, D Kondziolka, ME Linskey, JS Loeffler, M McDermott, MP Mehta, JJ Olson, RA Patchell, TC Ryken, SN Kalkanis. The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Ryken TC, M McDermott, PD Robinson, M Ammirati, DW Andrews, AL Asher, SH Burri, CS Cobbs, LE Gaspar, D Kondziolka, ME Linskey, JS Loeffler, MP Mehta, T Mikkelsen, JJ Olson, NA Paleologos, RA Patchell, SN Kalkanis. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Olson JJ, NA Paleologos, LE Gaspar, PD Robinson, RE Morris, M Ammirati, DW Andrews, AL Asher, SH Burri, CS Cobbs, D Kondziolka, ME Linskey, JS Loeffler, M McDermott, MP Mehta, T Mikkelsen, RA Patchell, TC Ryken, SN Kalkanis. The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. Journal of Neuro-Oncology, Volume 96, Number 1, January (I) 2010
• Rusthoven KE, Kavanaugh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Mulit-Instituitonal Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. Journal of Clinical Oncology. 2009 Apr 1;27(10):1572-8
• Rusthoven KE, Kavanaugh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases. Journal of Clinical Oncology. 2009 Apr 1;27(10):1579-84.
• Kent LM, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB. Radiation-Induced trismus in head and neck cancer patients. Support Care Cancer. 2008 Mar;16(3):305-9. Epub 2007 Oct 27
• Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri SH, Kwong E, Stea B. GliasSite Brachytherapy Boost as part of Initial Treatment of Glioblastoma Multiforme:A Retrospective Multi-Institutional Pilot Study. International Journal of Radiation Oncology Biology Physics 68(1):159-165. 2007.
• Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri SH, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncologica. 45(7):848-55. 2006.
• Gabayan AJ, Green S, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP,  Patel A, Amin P, Lustig R, Bastin K, Watson G, Burri SH, Stea B. GliaSite Brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery April 58(4):701-708. 2006.
• Burri SH, Asher AL.  Brain Metastases. Continuum: Neuro-Oncology, American Academy of Neurology. 11(5):13-29. 2005.
• Asher AL, Burri SH, Shaffrey ME,et.al.. Brain Metastases. Principles of Neuro-Oncology eds. David Schiff and Brian O’Neill, McGraw-Hill Professional, 2005.
• Shaffrey ME, Mut M, Asher A, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB, Markert JM, Schiff D, Siomin V, Tatter SB, Vogelbaum MA. Brain Metastases. Current Problems in Surgery Aug;41(8):665-741. 2004.
• Burri SH, Landry JC, Norton J, Davis LW.  Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy.  Journal of the National Medical Association July; 96(7):961-967. 2004.
• Burri SH, Asher A, Shaffrey M. In regard to Hasegawa et al. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery April 54(4):1033-1035. 2004.                
• Burri SH, Asher A. In regard to Regine et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. International Journal of Radiation Oncology Biology Physics Aug 1;53(5):1393-4. 2002.
• Burri SH, Landry JC, Davis LW. Breast conservation is an effective option in Black, medically indigent patients. Journal of the National Medical Association  Jun; 94(6):453-8. 2002.
• Burri SH, Kim CN, Fang G, Chang BS, Perkins C, Harris W, Davis LW, Thompson CB, Bhalla KN. ‘Loop’ Domain Deletional Mutant of Bcl-X_L is as effective as p29 Bcl-X_L in inhibiting Radiation-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and apoptosis. International Journal of Radiation Oncology Biology Physics 43:2 423-430. 1999.

• Glioblastoma Multiforme, Jonas M. Sheehan, Robert Cavaliere, Elena Farace, Markus Bredel and Stuart H. Burri Neurology Research International, Volume 2012 (2012), Article ID 819304.

• Poster Presentation.  The use of Glia-Site in the primary management of brain metastases results in a high rate of radiation necrosis and re-operation.  12^th Annual Meeting of the Society for Neuro-Oncology. Dallas, Texas. November 2007.
• Poster Presentation.  Neo-adjuvant pre-operative stereotactic radiosurgery in the management of brain metastases that require surgical resection.  57^th Annual Meeting of the Congress of Neurological Surgeons. San Diego, California. October 2007.
• Poster Presentation.  Pre-operative radiosurgery in the management of symptomatic brain metastases. 56^th Annual Meeting of the Congress of Neurological Surgeons.  Chicago, Illinois.  October 2006.
• Poster Presentation. Long-term follow-up of balloon-based brachytherapy (Glia-site) for treatment of high-grade gliomas and brain metastases is associated with a rising risk of radiation necrosis, but few late failures. 9^th Annual Meeting of the Society for Neuro-Oncology. Toronto, Ontario. November 2004.
• Poster Presentation. Encouraging early results using the Glia-Site brachytherapy device as a portion of initial therapy for malignant gliomas. 8^th  Annual Meeting of the Society for Neuro-Oncology. Keystone, Colorado. November 2003.
• Oral Presentation.  Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy.  42^nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO).  Boston, Massachusetts. October 2000.
• Oral Presentation.  Breast Conservation is an Effective Option in  Black, Medically Indigent Patients. 85^th Annual Meeting of the Radiologic Society of North America (RSNA). Chicago, Illinois. November 1999.
• Oral Presentation. ‘Loop” Domain Deletional Mutant of Bcl-X_L  is   as effective as p29 Bcl-X_L in inhibiting Radiation-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and Apoptosis.  40^th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO).  Phoenix, Arizona.  October, 1998.
• Oral Presentation Effect of Bcl-X_L or its ‘Loop’ Deletional Mutant Expression on irradiation-induced Cytosolic Cytochrome c, Caspase-3 Activity and Apoptosis.  89^th Annual Meeting of the American Association for Cancer Research (AACR).  New Orleans, Louisiana, 1998.

• Burri, SH, Abben C, Lanning KD, Williams PA. Physician Report Card Significantly Reduces Supplemenratary Requests for Documentation, Increasing Efficiency of the Professional Billing of a Large Single Specialty Radiation Oncology Practice. International Journal of Radiation Oncology • Biology • Physics: 99(2):E549. 2017.
• Heinzerling JH, Hampton CJ, Robinson M, Bright M, Symanowski JT, Moeller BJ, Mileham K, Burri SH, Foster RD. Use of 3D Optical Surface Mapping for Quantification of Interfraction Set up Error and Intrafraction Motion during Stereotactic Body Radiation Therapy Treatments of the Lung and Abdomen. International Journal of Radiation Oncology • Biology • Physics: 99(2):E670. 2017.
• Prabhu RS, Press RH, Boselli DM, Patel K, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola C, Asher A, Sumrall AL, Curran WJ, Jr., Shu HKG, Crocker IR, Burri SH. External validity of a nomogram predicting risk of 6-month and 9-month distant brain failure after initial stereotactic radiosurgery alone for brain metastases in an independent multi-institutional patient cohort. International Journal of Radiation Oncology • Biology • Physics;99:E525-E526. 2017.
• Press RH, Boselli DM, Patel K, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola C, Asher A, Sumrall AL, Curran WJ, Jr., Shu HKG, Crocker IR, Burri SH Prabhu RS. External validity of a nomogram and recursive partitioning analysis to predict for distant brain failure after stereotactic radiosurgery alone for brain metastases: Multi-institutional analysis. International Journal of Radiation Oncology • Biology • Physics;99:E101. 2017.
• Burri SH, Kelly RP, Symanowski J, Boltes M, Ballinger W, Wait SD, Haggstrom D, Sumrall A, Prabhu RS, Asher AL. Is There a Role for Stereotactic Biopsy of Unresectable Malignant Brain Lesions? An Analysis of Short-Term Morbidity and Mortality. International Journal of Radiation Oncology • Biology • Physics;96(2):E103. 2016
• Sumrall A, Haggstrom D, Perera S, Jennings D, Burri SH, Asher A. Using Bevacizumab to Manage Recurrent/Progressive Meningiomas: A Retrospective Analysis. Neuro-Oncology 18:S(6)vi105. 2016
• Patel K, Burri SH, Symanowski J, Boselli D, Sumrall A, Press RH, Fraser RW, Zhong J, Olson JJ, Curran WJ, Jr., Shu HKG, Crocker IR Prabhu RS. Comparing preoperative stereotactic radiosurgery (srs) to postoperative whole-brain radiation therapy (wbrt) for resectable brain metastases: A multi-institutional analysis. International Journal of Radiation Oncology • Biology • Physics;96:E85-E86. 2016.
• Press RH, Burri SH, Boselli D, Symanowski J, Patel K, Lankford S, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola C, Asher AL, Sumrall A, Curran WJ, Jr., Shu HK, Crocker IR, Prabhu RS. External validity of a risk stratification score predicting early distant brain failure and salvage whole-brain radiation therapy after stereotactic radiosurgery for brain metastases. International Journal of Radiation Oncology • Biology • Physics;96:E122. 2016.
• Sumrall A, Haggstrom D, Asher A, Crimaldi A, Prabhu R, Wait S,  Burri SH. Asseing the Safety of Combination Therapy with Bevacizumab and Optune for High Grade Gliomas. Neuro-Oncology 17: S(5), 1: v16. 2015.
• Sumrall A,  Haggstrom D, Asher A,  Crimaldi A, Prabhu R, Wait S, Burri SH. Managing Recurrent Grade III Gliomas with Combination Therapy of Bevacizumab and Optune. Neuro-Oncology 17:S(5):v16. 2015.
• Prabhu RS, Press RH, Patel KR, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Asher AL, Wait SD, Sumrall AL, Curran WJ, Shu H-KG, Crocker IR, Burri SH. Single fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS boost for large brain metastases: A multi-institutional analysis. ASCO Meeting Abstracts 2016;34:2076. 2015.
• Patel K, Asher A, Burri SH, Fraser RW, Kandula S, Press RH, Chen Z, Zhang C, Hadjipanayis CG, Olson J, Oyesiku N, Curran WJ, Jr., Shu HKG, Crocker IR, Prabhu RS. Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative SRS for Resectable Brain Metastases. International Journal of Radiation Oncology • Biology • Physics;93:S38-S39. BEST OF ASTRO 2015
• Crimaldi AJ, II, Walsh J, Symanowski J, Haake MR, McHaffie DR, Sharp HJ, Moeller BJ, Thakkar VV, McCammon RJ, Prabhu RS, Mitro GC, Konefal J, Trautmann TG, Plunkett SR, Fraser RW, Burri SH. Treatment (tx) of dupuytren’s contracture (dc) and ledderhose disease (ld) with radiation therapy (rt). International Journal of Radiation Oncology • Biology • Physics;93:E467. 2015.
• Prabhu RS, Patel KR, Burri SH, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Asher AL. Patterns of Recurrence and Toxicity for Pre-operative versus Post-operative Stereotactic Radiosurgery (SRS) for Resected Brain Metastases: A Multi-Institutional Analysis. Congress of Neurological Surgeons Annual Meeting 2015. Section on Tumors, Neurosurgical Forum.
• Heinzerling JH, McCammon RJ, Prabhu RS, Moeller BJ, Burri SH, Sharp HJ, McHaffie DR, Thakkar VV, Lankford SP, Butler JM, Crimaldi AJ, Haake MR, McCall BT, Mileham KF, Carrizosa DR, Haggstrom DE, Reames MK, Frenette GP, Kim ES, Fraser RW. Stereotactic Ablative Body Radiosurgery (SABR) in Early-Stage Lung Cancer: Can Results of Advanced Cancer Care in an Innovative De-Centralized Cancer Institute Replicate Favorable Clinical Trial Results? International Journal of Radiation Oncology • Biology • Physics;90:S613-S614. 2014
• Burri SH, Sumrall AL, Kelly RP, Boltes PO, Haggstrom DE, Prabhu RS, Smith MD, Ballinger WE, Symanowski JT, Fraser RW, Asher AL. Outcomes in patients with unresected gliomablastoma including assessment of bevacizumab as a component of initial therapy. Journal of Clinical Oncology: 32:15S(I) 131s. 2014.
• Sumrall A, Haggstrom D, Crimaldi A, Symanowski J, Giglio P, Asher A, Burri SH. Use of NovoTTF-100A in Heavily Pre-treated Patients with Relapsed High Grade Glioma : A Retrospective Chart Review. Neuro-Oncology 15(3) iii83. 2013.
• Burri SH, Asher AL, Mueller M, Fraser RW. The use of Glia-Site in the primary management of brain metastases results in a high rate of radiation necrosis and re-operation. Neuro-Oncology 9(4):586#RT-23. 2007.
• Sheehan J, Burri SH, Laws ER, Farace E. Delay in radiation leads to shorter length of survival in GBM:Analysis of the glioma outcomes data. Neuro-Oncology 9(4):581RT-3. 2007.
• Burri SH, Asher AL, Mueller ML, Cagle S, Fraser RW. Neo-adjuvant pre-operative stereotactic radiosurgery in the management of brain metastases that require surgical resection. Proceeding of Congress of Neurological Surgeons 57^th Annual Meeting San Diego, California October 2007.
• Burri SH, Asher AL, Fraser RW. Pre-operative Radiosurgery in the Management of Symptomatic Brain Metastases. Proceeding of Congress of Neurological Surgeons 56^th Annual Meeting Chicago, Illinois, October 2007.
• Burri SH, Asher AL, Norton HJ, Fraser RW. Long-term follow-up of balloon-based brachytherapy (Glia-site) for treatment of high-grade gliomas and brain metastases is associated with a rising risk of radiation necrosis, but few late failures. Neuro-Oncology 6(4):359#RT-03. 2004.
• Gabayan AJ, Sanan A, Bastin K, Burri SH, Green S, Jenrette J, Lustig R, Papagikos M, Patel A, Schultz C, Watson G, Stea B. Glia-Site radiation therapy system for the treatment of recurrent malignant glioma: A multi-institutional analysis. International Journal of Radiation Oncology Biology Physics 60:1S 258#1002. 2004.
• Gabayan AJ, Sanan A, Bastin K, Burri SH, Green S, Jenrette J, Lustig R, Papagikos M, Patel A, Schultz C, Watson G, Stea B. Glia-Site radiation therapy system for the treatment of recurrent malignant glioma: A multi-institutional analysis.  Radiotherapy and Oncology 71(2):S62. 2004.
• Burri SH, Sills AK, Fraser RW, Asher AL. Encouraging early results using the GliaSite brachytherapy device as a portion of initial therapy for malignant gliomas. Neuro-Oncology 5(4):349#TA-07. 2003.
• Burri SH, Landry JC, DeWolfe KD, Godette KD, Machuta SR, Davis LW.  Black and White Patients fare equally well when treated with Post-Lumpectomy Radiotherapy.  International Journal of Radiation Oncology Biology Physics 48:3S 196#169. 2000.
• Burri SH, Smith RG, Landry JC, Ghavidel S, Davis LW.  Breast    Conservation is an Effective Option in Black, Medically Indigent Patients.  Supplement to Radiology 213(P): 202#447.  November, 1999.
• Burri SH, Kim CN, Fang G, Davis LW, Bhalla KN. ‘Loop’ Domain Deletional Mutuant of Bcl-X_L is as effective as p29
• Bcl-X_L in inhibiting Radiaiton-Induced Cytosolic Accumulation of Cytochrome C, Caspase-3 Activity and Apoptosis.  International Journal of Radiation Oncology Biology Physics 42:1S 137#25. 1998.
• Burri SH, Liu L, Perkins C, Davis LW, Bhalla KN.  Effect of Bcl-X_L or its ‘Loop’ Deletional Mutant Expression on irradiation-induced Cytosolic Cytochrome C, Caspase-3 Activity and Apoptosis.  Proceedings of the American Association for Cancer Research 39: 78#530.  1998.

• “Stereotactic Radiaosurgery – The Ideal Treatment” Levine Cancer Institute Navigator Academy. Charlotte, NC. October 5, 2017.
• “Levine Cancer Institute : At the forefront of advancing the management of brain metastases”. Wake Forest-Levine Cancer Institute Scientific Symposium. Greensboro, NC. April 7, 2017.
• “Radiosurgery vs. WBRT: Effects on Cognitive Function.” Radiation therapy Symposium. Charlotte, NC. January 28, 2017 .
• “The Medical Physicist Value Proposition for Tomorrow and Today” American Academy of Medical Physicists (AAPM) Annual Meeting.  Washington, DC. July 31, 2016.
• “When to use Radiosurgery for Brain Metastases – Pre- or Post-Operative” Cleveland Clinic 7^th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine.  Las Vegas, NV. October 22, 2016
• “Controversies: Neo-adjuvant Radiosurgery Followed by Resection of Brain Metastases: Yes or No.” Congress of Neurological Surgeons (CNS) Annual Meeting. Boston, Massachusetts. October 20, 2014.
• “Clinical Trials: Are they really still necessary in 2014? Rationale, structure, and approach to modern clinical trials.” American Academy of Medical Dosimetrists (AAMD) national webinar. February 17, 2014.
• “Neo-adjuvant Radiosurgery” Cleveland Clinic 4th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine.  Las Vegas, NV. November 3, 2013.
• “Defining Optimal Treatment Strategies for Oligo-Cerebral Metastases” Cone Health Brain Tumor Update. Greensboro, NC. September 3, 2013
• “Local Therapies for High-Grade Gliomas” Levine Cancer Institute – Roper Brain Tumor Update.  Charleston, SC. November 2, 2012.
• “Stereotactic Radiosurgery – The Ideal Treatment” Grand Rounds – CaroMont Regional Medical Center. Gastonia, NC. May 22, 2012.
• “Extra-cranial Stereotactic Radiosurgery” Grand Rounds – Cleveland Regional Medical Center. Shelby, NC. November 30, 2009.
• “Extra-cranial Stereotactic Radioablation.” American Academy of Medical Dosimetrists Regional Meeting.  Myrtle Beach, SC. April 7, 2006.
• “Encouraging Early Results Using the GliaSite Brachytherapy Device as a Portion of Initial Therapy for Malignant Gliomas.” 2004 GliaSite Physician Conference. Chicago, Illinois. August 7, 2004.
• “Clinical Trial Development and Participation.” Society of Radiation Oncology Administrators: Southeast Regional Meeting. Charlotte, NC. June 26, 2004.
• “Intensity Modulated Radiation Therapy: The Future of Radiation Therapy.” Grand Rounds at Gaston Memorial Hospital. Gastonia, North Carolina. November 26, 2002.
• “Prostate Cancer and Intensity Modulated Radiation Therapy (IMRT)” Varian Sponsored IMRT Symposium. Charlotte, North Carolina. May 21, 2001.
• “New Techniques in Radiation Therapy: Stereotactic Radiosurgery, Stereotactic Radiotherapy, and IMRT” William R. Pitts Neuroscience Symposium. Charlotte, North Carolina.  May 1, 2001.
• “IMRT and Prostate Cancer” South Carolina Oncology Associates Annual Meeting.  Columbia, South Carolina. April 21, 2001.

• Co-Principal Investigator: “A Prospective Analysis of Neoadjuvant Radiosurgery and Surgical Resection for the Treatment of 1-3 Cerebral Metastases”, Carolinas Medical Center
• National Radiation Oncology Study Chair.  American College of Surgeons Oncology Group#Z0300: A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Metastases.
• Radiation Oncology Study Chair for multi-institutional study. Temozolomide as Neoadjuvant and Chemo-radiotherapy Following Resection and GLIADEL® Wafer Placement in Patients With Newly Diagnosed High-grade Glioma.